ArticleDrug design, development and therapy2018

Insight into resistance mechanism of anaplastic lymphoma kinase to alectinib and JH-VIII-157-02 caused by G1202R solvent front mutation.

Han Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.